{"name": "Tarsa Therapeutics",
 "permalink": "tarsa-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/tarsa-therapeutics",
 "homepage_url": "http://www.tarsatherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "267-273-7940",
 "description": "Oral formulation of Calcitonin",
 "created_at": "Wed Jan 20 07:35:50 UTC 2010",
 "updated_at": "Fri Mar 16 13:53:20 UTC 2012",
 "overview": "\u003Cp\u003ETarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       80],
      "assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],
     [[250,
       134],
      "assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],
     [[345,
       186],
      "assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President, Founder \u0026 Chief Executive Officer, Director",
    "person":
     {"first_name": "David",
      "last_name": "Brand",
      "permalink": "david-brand",
      "image": null}},
   {"is_past": false,
    "title": "Founder \u0026 Chief Scientific Officer",
    "person":
     {"first_name": "James",
      "last_name": "Gilligan",
      "permalink": "james-gilligan",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$76.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/tarsa-therapeutics-inc-series-a-24m/",
    "source_description": "Tarsa Therapeutics, Inc.: Series A $24M",
    "raised_amount": 24000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MVM Life Science Partners",
         "permalink": "mvm-life-science-partners",
         "image":
          {"available_sizes":
            [[[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-150x150.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-250x250.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo Ventures",
         "permalink": "novo-ventures",
         "image":
          {"available_sizes":
            [[[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/tarsa-therapeutics-adds-245m-financing-advances-osteoporosis-drug/2011-07-12?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Tarsa Therapeutics adds to $24.5M financing, advances osteoporosis drug",
    "raised_amount": 24500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 12,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.prnewswire.com/news-releases/tarsa-therapeutics-completes-28-million-series-b-financing-to-advance-ostora-oral-calcitonin-142908965.html",
    "source_description": "Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA\u2122 Oral Calcitonin",
    "raised_amount": 28000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Foresite Capital",
         "permalink": "foresite-capital",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0018/4163/184163v6-max-150x150.jpg"],
             [[250,
               43],
              "assets/images/resized/0018/4163/184163v6-max-250x250.jpg"],
             [[450,
               78],
              "assets/images/resized/0018/4163/184163v6-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MVM Life Science Partners",
         "permalink": "mvm-life-science-partners",
         "image":
          {"available_sizes":
            [[[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-150x150.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-250x250.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8 Penn Center, 1628 John F. Kennedy Boulevard",
    "address2": "Suite 1400",
    "zip_code": "19103-2124",
    "city": "Philadelphia",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0017/9172/179172v1-max-150x150.jpg"],
      [[250,
        166],
       "assets/images/resized/0017/9172/179172v1-max-250x250.jpg"],
      [[450,
        299],
       "assets/images/resized/0017/9172/179172v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}